Trial Profile
A phase I pharmacokinetic study of topiramate extended-release in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Apr 2024
Price :
$35
*
At a glance
- Drugs Topiramate (Primary)
- Indications Epilepsy
- Focus Pharmacokinetics
- 04 Apr 2024 According to a Ligand Pharmaceuticals media release, today announced that its partners at the University of Minnesota (UMN) and CURx Pharmaceuticals, Inc presented preliminary pharmacokinetic data from 25 healthy participants in a poster which was featured at the 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference in London, England.
- 24 Jun 2013 Results will be presented at the 30th International Epilepsy Congress (IEC) in 2013.
- 02 Dec 2011 New trial record